Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE

https://doi.org/10.20996/1819-6446-2010-6-3-311-317

Full Text:

Abstract

Aim. To evaluate the anemia prevalence and its impact on chronic heart failure (CHF) course.

Methods. A total of 228 outpatients (86 women and 196 men, aged 39-85 y.o.) with clinically stable CHF (II-IV functional class according to NYHA) were studied. Anemia was defined by the WHO criteria (hemoglobin levels <13 g/dl in men and <12 g/dl in women).

Results. Anemia was found in 18,8% of CHF patients. In all the cases anemia was mild (hemoglobin levels >9 g/dl). Anemia rate did not differ significantly in patients with reduced (18,5%) and preserve (19,1%) or left ventricle ejection fraction (LV EF) (р=0,743). Anemic and non anemic patients were similar in terms of gender, NYHA functional class, heart rate and LV EF. The rate of anemic patients increased significantly up to 35,8% in creatinine clearance <60ml/min. Anemic patients were older (p<0,001), had longer CHF duration (p=0,014), lower body mass index (p=0,041), had diabetes more often (p=0,004, χ2=8,01) in comparison with non anemic patients. Deficiency of iron, vita￾min B12 or folic acid was a reason of anemia in 35,8%, 9,4% and 15,1% of patients, respectively. Anemia reason was not detected in 39,7% of patients.

Conclusion. Anemia in patients with CHF is associated with age, impaired renal function, diabetes and high hospitalization rate because of CHF deterioration.

About the Authors

V. N. Larina
Russian State Medical University
Russian Federation
Ostrovityaninova ul. 1, Moscow, 117997


B. Ya. Bart
Russian State Medical University
Russian Federation
Ostrovityaninova ul. 1, Moscow, 117997


V. G. Larin
Russian State Medical University
Russian Federation
Ostrovityaninova ul. 1, Moscow, 117997


References

1. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. Национальные Рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). Журнал Сердечная недостаточность 2007;8(1):4-41.

2. Dickstein K., Cohen-Solal A., Filippatos G. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29(19):2388-442.

3. Терещенко С.Н.,Атрощенко Е.С., Ускач Т.М. и др. Анемия как осложнение хронической сердечной недостаточности: распространённость, прогноз и лечение. Тер арх 2008;80(9):90-4.

4. Opasich C., Cazzola M., Scelsi L. et al. Blunted erythropoeton production and defective iron supply for erythropoesis as major cause of anaemia in patients with chronic heart failure. Eur Heart J 2005;26(21):2232-7.

5. Silverberg D.S., Wexler D., Blum M. et al. The interaction between heart failure, renal failure and anemia – the cardio-renal anemia syndrome. Blood Purif 2004;22(3):277-84.

6. Anand I., McMurray J.J., Whitmore J. et al. Anemia and its relationship to clinical outcome in heart fail￾ure. Circulation 2004;110(2):149-54.

7. Cromie N., Lee C., Struthers AD. Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? Heart 2002;87(4):377-8.

8. Tang W.H., Tong W.,Jain A. et al. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2008;51(5):569- 76.

9. Aronson D., Suleiman M., Agmon Y. et al. Changes in Hb levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 2007;28(11):1289-96.

10. Беленков Ю.Н., Мареев В.Ю. Принципы рационального лечения сердечной недостаточности. М.: Медиа Медика; 2000.

11. Rector T.S., Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992;124(4):1017-25.

12. Guyatt G.H. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993;22 (4 Suppl A):185A-191A.

13. Guyatt G.H., Thompson P.J., Berman L.B. et al.How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985;38(6):517-24.

14. Levey A., Bosch J., Lewis J. at al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 1999;16;130(6):461-70

15. Silverberg D.S., Wexler D., Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002;4(6):681-6.

16. Witte K.K., Desilva R., Chattopadhyay S. et al. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 2004;147(5):924-30.

17. Терещенко С.Н., ДжаинаниН.А., Ускач Т.М., Кочетов А.Г. Анемия и хроническая сердечная недостаточность. Кардиология 2004;44(7):73-6.

18. Horwich T.B., Fonarow G.C., Hamilton M.A. et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39(11):1780-6.

19. Komajda M. Prevalence of anemia in patients with chronic heart failure and their clinical characteristics. J Card Fail 2004;10(1 Suppl):S1-4.

20. Adlbercht C., Kommata S., Hulsmann M. et al. Chronic heart failure leads to an expanded plasma volume and pseudoanemia, but does not lead to a reduction in the body’s red cell volume. Eur Heart J 2008;29(19):2343-50.

21. O'Meara E., Clayton T., McEntegart M. et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006;113(7):986-94.

22. Valeur N., Nielsen O.W., McMurray J.J. et al. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail 2006;8(6):577-84.

23. Maggioni A.P., Opasich C., Anand I. et al. Anemia in patients with heart failure: prevalence and prog￾nostic role in a controlled trial and in clinical practice. J Card Fail 2005;11(2):91-8.

24. Стаценко М.Е., Спорова О.Е., Беленкова С.В., Иванова Д.А. Возрастные особенности морфофункциональных параметров сердца, вариабельности ритма сердца, состояния почек и качества жизни у больных хронической сердечной недостаточностью. Журнал Сердечная недостаточность 2007;8(3):127-30.

25. Арутюнов Г.П. Патофизиологические процессы в почках у больных ХСН. Журнал Сердечная недостаточность 2008;9(5):234-49.

26. Резник Е.В., Гендлин Г.Е., Сторожаков Г.И., Волынкина В.М. Почечная гемодинамика у больных хронической сердечной недостаточностью. Журнал Сердечная недостаточность 2007;8(3): 118-25.

27. Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and is associated with poor prognosis. Circulation 2003;107(2):223-5.

28. Мухин Н.А., Моисеев В.С., Кобалава Ж.Д и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер арх 2004;76(6):39-46.

29. Mancini D.M., Katz S.D., Lang C.C. et al. The effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003;107(2):294-9.

30. SilverbergD.S., Wexler D., Blum M. et al. Erythropoetin should be part of congestive heart failure management. Kidney Int Suppl 2003;(87):S40-7.

31. Резник Е.В., Гендлин Г.Е., Сторожаков Г.И. Дисфункция почек у больных хронической сердечной недостаточностью: патогенез, диагностика, лечение. Журнал Сердечная недостаточность 2005;6(6):245-50.

32. De Silva R., Nikitin N.P., Witte K.K. et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006;27(5):569-81.

33. Silverberg D., Wexler D., Iaina A., Schwartz D. The role of correction of anaemia in patients with congestive heart failure. Eur J Heart Fail 2008; 10(9): 819-823

34. Androne A., Katz S., Lund L. et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107(2):226-9.

35. Westenbrink B.D., Visser F.W., Voors A.A. et al. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoetin production, but to fluid retention as well. EurHeart J 2007;28(2):166-171.

36. Гончарова Е.В., Говорин А.В., Кузьмин А.Г. Показатели кардиогемодинамики у больных хронической железодефицитной анемией. Журнал Сердечная недостаточность 2007;8(6): 289-93.


For citation:


Larina V.N., Bart B.Y., Larin V.G. CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE. Rational Pharmacotherapy in Cardiology. 2010;6(3):311-317. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-3-311-317

Views: 439


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)